By: Skip Raschke of OptionsProfits Every (well almost) Saturday morning I have my coffee while rummaging through my latest Barrons and, the weekend edition of “Investor’s Business Daily”. I generally skip over the waste-of-my-time stuff with IBD, going instead to the second section of that paper in order to peruse the “IBD 50” gang of growth stocks that pass muster as per the collective genii…
View the full post at http://blog.t3live.com
